Madhan Selvaraj

from Chennai, India
at present: PhD student in Pospisilik lab

Address:
Max Planck Institute of Immunobiology and Epigenetics
Stuebeweg 51
D-79108 Freiburg

Tel. +49 (0) 761 5108 793
Fax +49 (0) 761 5108 720
e-mail:

Curriculum vitae:
2010 - present IMPRS-MCB Program
2007 - 2010 Assistant research officer, TLL, National University of Singapore
2006 - 2007 Research student, BRI, National Research Council Canada
2005 - 2007 Master of Science Applied in Biotechnology, McGill University, Montreal, Canada
2001 - 2005 Bachelor of Technology in Biotechnology, St. Peter's College, Chennai, India

Research interests and goals:
I've always believed that knowledge is of little use until it is applied in a beneficial way to society. I have always worked in accordance with the above-mentioned words and have set my objective on contributing to mankind, by doing innovative research to combat molecular diseases. As a Biotechnology graduate, I am keen to expand my expertise in the field of biomedical sciences as it is among the best ways to work towards relieving most of the human ailments. With the extensive knowledge that I have gained in cell and molecular biology as well as biochemistry through the years of education and research, I believe that I am well prepared for further challenging studies and research in the field of disease biology. At IMPRS-MCB I am particularly interested in understanding the epigenetic principles that underlie the altered biological phenomena in diseased cells.

Publications:

Madhan S, Prabakaran M, Chang T and Kwang J. 2010. Baculovirus as a vaccine vectors. Current Gene Therapy 10: 201-13.
Prabakaran M, Madhan S, Prabhu N, Qiang J and Kwang J. 2010. Gastrointestinal delivery of baculovirus displaying influenza hemagglutinin protects mice against heterologous H5N1 infection. Journal of Virology 84: 3201-9.
Prabakaran M, He F, Meng T, Madhan S, Yunrui T, Jia Q, Kwang J. 2010. Neutralizing epitopes of influenza virus hemagglutinin: Target for the development of universal vaccine against H5N1 lineages. Journal of Virology Sept 15.
Prabakaran M, Madhan S, Prabhu N and Kwang J. 2010. Reverse-micelle encapsulated recombinant baculovirus as an oral vaccine against H5N1 infection in mice. Antiviral Research 86: 180-7.
He F, Madhan S and Kwang J. 2009. Baculovirus vector as a delivery vehicle for influenza vaccines. Expert Review of Vaccines 8: 455-67.
Syed Musthaq S, Madhan S, Sahul Hameed AS, Kwang J. 2009. Localization of VP28 on the baculovirus envelope and its immunogenicity against White Spot Syndrome Virus in Penaeus monodon. Virology 391: 315-24.